San Mateo, Calif. — September 10, 2020 –RapidAI, the worldwide leader in advanced imaging for stroke, today announced the launch of the Rapid Web App as well as ISO 27001 data security and management certification. The addition of the Rapid Web App delivers another way for stroke teams to conveniently preview and interact with Rapid® results and communicate securely. In parallel RapidAI’s ISO 27001 certification acknowledges the company’s significant security and privacy protection protocols.
The new Rapid Web App extends access into yet another user environment, offering stroke team members a convenient way to view real-time browser notifications of new cases, preview Rapid results and source files, and enable workflow communications via a desktop or laptop. The app works with Google Chrome and Microsoft Edge browsers to give users an easy way to view, organize, and track cases from multiple sites in one location.
“It takes a whole team to treat stroke and we want to ensure our tools meet the team where they are – whether on a phone, desktop, or a laptop,” said Rachel Witalec, Vice President of Product at RapidAI. “With the Rapid Web App team members now have even more ways to ensure they can collaborate and preview time-sensitive stroke imaging across their workflow.”
With the Rapid Web App
Stay updated: The Rapid Web App delivers new case information to physicians through browser notifications. It saves precious time by giving users the option to preview Rapid results and compressed patient images directly from a desktop or laptop.
Faster treatment decisions: The powerful Rapid clinical backend delivers processed imaging results based on NCCT, CTP, CTA and MRI (diffusion and perfusion) scans to the Rapid Web App in minutes. The app helps facilitate faster treatment decisions by giving physicians the ability to immediately preview Rapid results and source files through the built-in Image viewer.
Streamlining patient care: The Rapid Web App’s collaboration features facilitate and accelerate acute care coordination. Stroke team members can communicate within the app—centralizing case information, communicating team activation, limiting touchpoints, and reducing miscommunications.
Secure, Compliant Access & Communications: The Rapid Web App is integrated with third-party identity providers such as Microsoft Active Directory to support single sign-on and easier activation and deactivation of Rapid Web App accounts. The secure, GDPR and HIPAA-compliant Rapid Web App provides the tools hospitals need to support stroke-care operations.
Data security & compliance with ISO 27001
Building on RapidAI’s commitment to secure and compliant data management, today the company also announced it has received ISO 27001 certification, a rigorous information security standard that demonstrates RapidAI’s investment in the people, processes, and technology to protect its platform and data. In addition to a National Institute of Standards and Technology (NIST) cybersecurity framework, RapidAI is HIPAA compliant, GDPR compliant, ISO 13485 and ISO 27001 certified.
RapidAI makes the most-widely used stroke imaging software for patient care, research, and clinical trials—helping hospitals around the world save time, money, and lives. Rapid is the only clinically validated platform available and considered by many to be the gold standard for advanced cerebrovascular imaging.
To learn more visit www.RapidAI.com.
RapidAI is the worldwide leader in advanced imaging for stroke. Based on intelligence gained over 1,000,000 scans from more than 1,600 hospitals in over 50 countries, the Rapid® platform uses artificial intelligence to create high quality, advanced images from non-contrast CT, CT angiography, CT perfusion, and MRI diffusion and perfusion scans. The Rapid imaging platform includes Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, and Rapid MRI. RapidAI also offers SurgicalPreview®, a comprehensive aneurysm management platform.
RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically-proven, data-driven technology. With our validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day. For more information, visit RapidAI.com.